Oxytocin Augmentation for Active Phase Protraction Disorder
Definition and Diagnosis
- The American College of Obstetricians and Gynecologists defines active phase protraction disorder as a slower than expected rate of cervical dilatation, with a threshold of ≥1.5 cm/hour for multiparas 1
- A patient with a rate of 0.25 cm/hour over 4 hours is significantly below the normal threshold, confirming protracted active phase 1, 2
- The active phase begins when cervical dilatation accelerates, typically around 5-6 cm, regardless of specific dilatation achieved 3, 1
Treatment with Oxytocin
- Oxytocin augmentation achieves a 92% vaginal delivery success rate for active phase protraction disorder when cephalopelvic disproportion (CPD) is not evident 2
- The American College of Obstetricians and Gynecologists recommends oxytocin augmentation as the first-line intervention for protraction disorder 2
- Target adequate contractions (≥200 Montevideo units) with oxytocin augmentation 4
Critical Assessment Before Starting Oxytocin
- Evaluate for factors suggesting CPD, including fetal factors (macrosomia, malposition, malpresentation, excessive molding or asynclitism) 5, 6, 2
- Evaluate for maternal factors (diabetes, obesity, advanced age, small pelvic dimensions) 5, 6, 2
- Clinical signs of CPD include increasingly marked molding, deflexion, or asynclitism without descent 6
Expected Response and Monitoring
- If no progress occurs after 4 hours of adequate oxytocin augmentation (≥200 Montevideo units), reassess for CPD and consider cesarean delivery 6, 2
- Recent evidence suggests 2 hours may be safer than 4 hours for determining oxytocin failure 6
- Discontinue oxytocin immediately if fetal distress or uterine hyperactivity occurs 2